International Multicentre, Observational, Non-Interventional Prospective Study of Azilsartan Medoxomil in Patients With Arterial Hypertension Who Are Overweight or Obese in the Russian Federation and The Republic of Kazakhstan
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 09 Nov 2017
At a glance
- Drugs Azilsartan medoxomil (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Takeda
- 02 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2017 Planned End Date changed from 1 Apr 2018 to 1 Sep 2018.
- 11 Sep 2017 Planned primary completion date changed from 1 Apr 2018 to 1 Sep 2018.